APO Research
Talk to an analyst

APO RESEARCH · REPORT

Short-acting Nicotine Product

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Short-acting Nicotine Product Market Outlook and Growth Opportunities 2026

5 June 2026197 pages

Choose your research edition.

Industry ResearchShort-acting Nicotine Product Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Short-acting Nicotine Product Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Short-acting Nicotine Product Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Short-acting Nicotine Product Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Short-acting Nicotine Product Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Short-acting Nicotine Product market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Short-acting Nicotine Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Short-acting Nicotine Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Short-acting Nicotine Product is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Short-acting Nicotine Product market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Short-acting Nicotine Product market include Nicorette (Johnson & Johnson), Nicotinell (Haleon), Equate (Walmart), Thrive (Haleon), NiQuitin (Perrigo), Philip Morris, Alkalon, LUCY GOODS and Dr. Reddy's Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Short-acting Nicotine Product market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Short-acting Nicotine Product and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Short-acting Nicotine Product sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Short-acting Nicotine Product market size, projected growth trends, production technologies, key applications, and end-use industries.

Short-acting Nicotine Product Segment by Company

Nicorette (Johnson & Johnson)

Nicotinell (Haleon)

Equate (Walmart)

Thrive (Haleon)

NiQuitin (Perrigo)

Philip Morris

Alkalon

LUCY GOODS

Dr. Reddy's Laboratories

Nicotex (Cipla Health)

Swedish Match

Altria

British American Tobacco (BAT)

Skruf Snus

Japan Tobacco International (JTI)

Short-acting Nicotine Product Segment by Type

Nicotine Gum

Nicotine Lozenge

Nasal Spray

Oral Inhaler

Nicotine Pouches

Short-acting Nicotine Product Segment by Application

Online Sales

Offline Sales

Short-acting Nicotine Product Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Short-acting Nicotine Product status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Short-acting Nicotine Product market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Short-acting Nicotine Product significant trends, drivers, influence factors in global and regions.

6. To analyze Short-acting Nicotine Product competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Short-acting Nicotine Product market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Short-acting Nicotine Product and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Short-acting Nicotine Product.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Short-acting Nicotine Product market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Short-acting Nicotine Product industry.

Chapter 3: Detailed analysis of Short-acting Nicotine Product manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Short-acting Nicotine Product in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Short-acting Nicotine Product in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Short-acting Nicotine Product Industry Trends Table 2. Short-acting Nicotine Product Industry Drivers Table 3. Short-acting Nicotine Product Industry Opportunities and Challenges Table 4. Short-acting Nicotine Product Industry Restraints Table 5. Global Short-acting Nicotine Product Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Short-acting Nicotine Product Revenue Share by Company (2021-2026) Table 7. Global Short-acting Nicotine Product Sales Volume by Company (k units) & (2021-2026) Table 8. Global Short-acting Nicotine Product Sales Volume Share by Company (2021-2026) Table 9. Global Short-acting Nicotine Product Average Price (USD/unit) of Company (2021-2026) Table 10. Global Short-acting Nicotine Product Company Ranking, (2024-2026) & (USD Million) Table 11. Global Short-acting Nicotine Product Key Company Manufacturing Base & Headquarters Table 12. Global Short-acting Nicotine Product Company, Product Type & Application Table 13. Global Short-acting Nicotine Product Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Short-acting Nicotine Product by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Nicotine Gum Table 18. Significant Companies of Nicotine Lozenge Table 19. Significant Companies of Nasal Spray Table 20. Significant Companies of Oral Inhaler Table 21. Significant Companies of Nicotine Pouches Table 22. Global Short-acting Nicotine Product Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Short-acting Nicotine Product Sales Volume by Type (2021-2026) & (k units) Table 24. Global Short-acting Nicotine Product Sales Volume by Type (2027-2032) & (k units) Table 25. Global Short-acting Nicotine Product Sales Volume Share by Type (2021-2026) Table 26. Global Short-acting Nicotine Product Sales Volume Share by Type (2027-2032) Table 27. Global Short-acting Nicotine Product Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Short-acting Nicotine Product Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Short-acting Nicotine Product Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Short-acting Nicotine Product Sales Value Share by Type (2021-2026) Table 31. Global Short-acting Nicotine Product Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Online Sales Table 33. Significant Companies of Offline Sales Table 34. Global Short-acting Nicotine Product Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global Short-acting Nicotine Product Sales Volume by Application (2021-2026) & (k units) Table 36. Global Short-acting Nicotine Product Sales Volume by Application (2027-2032) & (k units) Table 37. Global Short-acting Nicotine Product Sales Volume Share by Application (2021-2026) Table 38. Global Short-acting Nicotine Product Sales Volume Share by Application (2027-2032) Table 39. Global Short-acting Nicotine Product Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Short-acting Nicotine Product Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Short-acting Nicotine Product Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Short-acting Nicotine Product Sales Value Share by Application (2021-2026) Table 43. Global Short-acting Nicotine Product Sales Value Share by Application (2027-2032) Table 44. Global Short-acting Nicotine Product Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global Short-acting Nicotine Product Sales by Region (2021-2026) & (k units) Table 46. Global Short-acting Nicotine Product Sales Market Share by Region (2021-2026) Table 47. Global Short-acting Nicotine Product Sales by Region (2027-2032) & (k units) Table 48. Global Short-acting Nicotine Product Sales Market Share by Region (2027-2032) Table 49. Global Short-acting Nicotine Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Short-acting Nicotine Product Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Short-acting Nicotine Product Sales Value Share by Region (2021-2026) Table 52. Global Short-acting Nicotine Product Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Short-acting Nicotine Product Sales Value Share by Region (2027-2032) Table 54. Global Short-acting Nicotine Product Market Average Price (USD/unit) by Region (2021-2026) Table 55. Global Short-acting Nicotine Product Market Average Price (USD/unit) by Region (2027-2032) Table 56. Global Short-acting Nicotine Product Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global Short-acting Nicotine Product Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Short-acting Nicotine Product Sales by Country (2021-2026) & (k units) Table 59. Global Short-acting Nicotine Product Sales Market Share by Country (2021-2026) Table 60. Global Short-acting Nicotine Product Sales by Country (2027-2032) & (k units) Table 61. Global Short-acting Nicotine Product Sales Market Share by Country (2027-2032) Table 62. Global Short-acting Nicotine Product Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Short-acting Nicotine Product Sales Value Market Share by Country (2021-2026) Table 64. Global Short-acting Nicotine Product Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Short-acting Nicotine Product Sales Value Market Share by Country (2027-2032) Table 66. Nicorette (Johnson & Johnson) Company Information Table 67. Nicorette (Johnson & Johnson) Business Overview Table 68. Nicorette (Johnson & Johnson) Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 69. Nicorette (Johnson & Johnson) Short-acting Nicotine Product Product Portfolio Table 70. Nicorette (Johnson & Johnson) Recent Development Table 71. Nicotinell (Haleon) Company Information Table 72. Nicotinell (Haleon) Business Overview Table 73. Nicotinell (Haleon) Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Nicotinell (Haleon) Short-acting Nicotine Product Product Portfolio Table 75. Nicotinell (Haleon) Recent Development Table 76. Equate (Walmart) Company Information Table 77. Equate (Walmart) Business Overview Table 78. Equate (Walmart) Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Equate (Walmart) Short-acting Nicotine Product Product Portfolio Table 80. Equate (Walmart) Recent Development Table 81. Thrive (Haleon) Company Information Table 82. Thrive (Haleon) Business Overview Table 83. Thrive (Haleon) Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Thrive (Haleon) Short-acting Nicotine Product Product Portfolio Table 85. Thrive (Haleon) Recent Development Table 86. NiQuitin (Perrigo) Company Information Table 87. NiQuitin (Perrigo) Business Overview Table 88. NiQuitin (Perrigo) Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. NiQuitin (Perrigo) Short-acting Nicotine Product Product Portfolio Table 90. NiQuitin (Perrigo) Recent Development Table 91. Philip Morris Company Information Table 92. Philip Morris Business Overview Table 93. Philip Morris Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Philip Morris Short-acting Nicotine Product Product Portfolio Table 95. Philip Morris Recent Development Table 96. Alkalon Company Information Table 97. Alkalon Business Overview Table 98. Alkalon Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Alkalon Short-acting Nicotine Product Product Portfolio Table 100. Alkalon Recent Development Table 101. LUCY GOODS Company Information Table 102. LUCY GOODS Business Overview Table 103. LUCY GOODS Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. LUCY GOODS Short-acting Nicotine Product Product Portfolio Table 105. LUCY GOODS Recent Development Table 106. Dr. Reddy's Laboratories Company Information Table 107. Dr. Reddy's Laboratories Business Overview Table 108. Dr. Reddy's Laboratories Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Dr. Reddy's Laboratories Short-acting Nicotine Product Product Portfolio Table 110. Dr. Reddy's Laboratories Recent Development Table 111. Nicotex (Cipla Health) Company Information Table 112. Nicotex (Cipla Health) Business Overview Table 113. Nicotex (Cipla Health) Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Nicotex (Cipla Health) Short-acting Nicotine Product Product Portfolio Table 115. Nicotex (Cipla Health) Recent Development Table 116. Swedish Match Company Information Table 117. Swedish Match Business Overview Table 118. Swedish Match Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Swedish Match Short-acting Nicotine Product Product Portfolio Table 120. Swedish Match Recent Development Table 121. Altria Company Information Table 122. Altria Business Overview Table 123. Altria Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Altria Short-acting Nicotine Product Product Portfolio Table 125. Altria Recent Development Table 126. British American Tobacco (BAT) Company Information Table 127. British American Tobacco (BAT) Business Overview Table 128. British American Tobacco (BAT) Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. British American Tobacco (BAT) Short-acting Nicotine Product Product Portfolio Table 130. British American Tobacco (BAT) Recent Development Table 131. Skruf Snus Company Information Table 132. Skruf Snus Business Overview Table 133. Skruf Snus Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Skruf Snus Short-acting Nicotine Product Product Portfolio Table 135. Skruf Snus Recent Development Table 136. Japan Tobacco International (JTI) Company Information Table 137. Japan Tobacco International (JTI) Business Overview Table 138. Japan Tobacco International (JTI) Short-acting Nicotine Product Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Japan Tobacco International (JTI) Short-acting Nicotine Product Product Portfolio Table 140. Japan Tobacco International (JTI) Recent Development Table 141. Key Raw Materials Table 142. Raw Materials Key Suppliers Table 143. Short-acting Nicotine Product Distributors List Table 144. Short-acting Nicotine Product Customers List Table 145. Research Programs/Design for This Report Table 146. Authors List of This Report Table 147. Secondary Sources Table 148. Primary Sources List of Figures Figure 1. Short-acting Nicotine Product Product Image Figure 2. Global Short-acting Nicotine Product Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Short-acting Nicotine Product Sales Value (2021-2032) & (US$ Million) Figure 4. Global Short-acting Nicotine Product Sales (2021-2032) & (k units) Figure 5. Global Short-acting Nicotine Product Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Short-acting Nicotine Product Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Nicotine Gum Image Figure 10. Nicotine Lozenge Image Figure 11. Nasal Spray Image Figure 12. Oral Inhaler Image Figure 13. Nicotine Pouches Image Figure 14. Global Short-acting Nicotine Product Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Short-acting Nicotine Product Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Short-acting Nicotine Product Sales Volume Share by Type (2021-2032) Figure 17. Global Short-acting Nicotine Product Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Short-acting Nicotine Product Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Short-acting Nicotine Product Sales Value Share by Type (2021-2032) Figure 20. Online Sales Image Figure 21. Offline Sales Image Figure 22. Global Short-acting Nicotine Product Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Short-acting Nicotine Product Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Short-acting Nicotine Product Sales Volume Share by Application (2021-2032) Figure 25. Global Short-acting Nicotine Product Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Short-acting Nicotine Product Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Short-acting Nicotine Product Sales Value Share by Application (2021-2032) Figure 28. Global Short-acting Nicotine Product Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global Short-acting Nicotine Product Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Short-acting Nicotine Product Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Short-acting Nicotine Product Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Short-acting Nicotine Product Sales Value (2021-2032) & (US$ Million) Figure 33. North America Short-acting Nicotine Product Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Short-acting Nicotine Product Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Short-acting Nicotine Product Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Short-acting Nicotine Product Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Short-acting Nicotine Product Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Short-acting Nicotine Product Sales Value (2021-2032) & (US$ Million) Figure 39. South America Short-acting Nicotine Product Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Short-acting Nicotine Product Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Short-acting Nicotine Product Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Short-acting Nicotine Product Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Short-acting Nicotine Product Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Short-acting Nicotine Product Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Nicotine Gum
  • Nicotine Lozenge
  • Nasal Spray
  • Oral Inhaler
  • Nicotine Pouches
Applications
  • Online Sales
  • Offline Sales
Companies covered
  • Nicorette (Johnson & Johnson)
  • Nicotinell (Haleon)
  • Equate (Walmart)
  • Thrive (Haleon)
  • NiQuitin (Perrigo)
  • Philip Morris
  • Alkalon
  • LUCY GOODS
  • Dr. Reddy's Laboratories
  • Nicotex (Cipla Health)
  • Swedish Match
  • Altria
  • British American Tobacco (BAT)
  • Skruf Snus
  • Japan Tobacco International (JTI)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Short-acting Nicotine Product Sales Value (2021-2032)
  4. 1.2.2 Global Short-acting Nicotine Product Sales Volume (2021-2032)
  5. 1.2.3 Global Short-acting Nicotine Product Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Short-acting Nicotine Product Market Dynamics
  1. 2.1 Short-acting Nicotine Product Industry Trends
  2. 2.2 Short-acting Nicotine Product Industry Drivers
  3. 2.3 Short-acting Nicotine Product Industry Opportunities and Challenges
  4. 2.4 Short-acting Nicotine Product Industry Restraints
3 Short-acting Nicotine Product Market by Company
  1. 3.1 Global Short-acting Nicotine Product Company Revenue Ranking in 2025
  2. 3.2 Global Short-acting Nicotine Product Revenue by Company (2021-2026)
  3. 3.3 Global Short-acting Nicotine Product Sales Volume by Company (2021-2026)
  4. 3.4 Global Short-acting Nicotine Product Average Price by Company (2021-2026)
  5. 3.5 Global Short-acting Nicotine Product Company Ranking (2024-2026)
  6. 3.6 Global Short-acting Nicotine Product Company Manufacturing Base and Headquarters
  7. 3.7 Global Short-acting Nicotine Product Company Product Type and Application
  8. 3.8 Global Short-acting Nicotine Product Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Short-acting Nicotine Product Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Short-acting Nicotine Product Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Short-acting Nicotine Product Market by Type
  1. 4.1 Short-acting Nicotine Product Type Introduction
  2. 4.1.1 Nicotine Gum
  3. 4.1.2 Nicotine Lozenge
  4. 4.1.3 Nasal Spray
  5. 4.1.4 Oral Inhaler
  6. 4.1.5 Nicotine Pouches
  7. 4.2 Global Short-acting Nicotine Product Sales Volume by Type
  8. 4.2.1 Global Short-acting Nicotine Product Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Short-acting Nicotine Product Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Short-acting Nicotine Product Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Short-acting Nicotine Product Sales Value by Type
  12. 4.3.1 Global Short-acting Nicotine Product Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Short-acting Nicotine Product Sales Value by Type (2021-2032)
  14. 4.3.3 Global Short-acting Nicotine Product Sales Value Share by Type (2021-2032)
5 Short-acting Nicotine Product Market by Application
  1. 5.1 Short-acting Nicotine Product Application Introduction
  2. 5.1.1 Online Sales
  3. 5.1.2 Offline Sales
  4. 5.2 Global Short-acting Nicotine Product Sales Volume by Application
  5. 5.2.1 Global Short-acting Nicotine Product Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Short-acting Nicotine Product Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Short-acting Nicotine Product Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Short-acting Nicotine Product Sales Value by Application
  9. 5.3.1 Global Short-acting Nicotine Product Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Short-acting Nicotine Product Sales Value by Application (2021-2032)
  11. 5.3.3 Global Short-acting Nicotine Product Sales Value Share by Application (2021-2032)
6 Short-acting Nicotine Product Regional Sales and Value Analysis
  1. 6.1 Global Short-acting Nicotine Product Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Short-acting Nicotine Product Sales by Region (2021-2032)
  3. 6.2.1 Global Short-acting Nicotine Product Sales by Region: 2021-2026
  4. 6.2.2 Global Short-acting Nicotine Product Sales by Region (2027-2032)
  5. 6.3 Global Short-acting Nicotine Product Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Short-acting Nicotine Product Sales Value by Region (2021-2032)
  7. 6.4.1 Global Short-acting Nicotine Product Sales Value by Region: 2021-2026
  8. 6.4.2 Global Short-acting Nicotine Product Sales Value by Region (2027-2032)
  9. 6.5 Global Short-acting Nicotine Product Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Short-acting Nicotine Product Sales Value (2021-2032)
  12. 6.6.2 North America Short-acting Nicotine Product Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Short-acting Nicotine Product Sales Value (2021-2032)
  15. 6.7.2 Europe Short-acting Nicotine Product Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Short-acting Nicotine Product Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Short-acting Nicotine Product Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Short-acting Nicotine Product Sales Value (2021-2032)
  21. 6.9.2 South America Short-acting Nicotine Product Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Short-acting Nicotine Product Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Short-acting Nicotine Product Sales Value Share by Country, 2025 VS 2032
7 Short-acting Nicotine Product Country-level Sales and Value Analysis
  1. 7.1 Global Short-acting Nicotine Product Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Short-acting Nicotine Product Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Short-acting Nicotine Product Sales by Country (2021-2032)
  4. 7.3.1 Global Short-acting Nicotine Product Sales by Country (2021-2026)
  5. 7.3.2 Global Short-acting Nicotine Product Sales by Country (2027-2032)
  6. 7.4 Global Short-acting Nicotine Product Sales Value by Country (2021-2032)
  7. 7.4.1 Global Short-acting Nicotine Product Sales Value by Country (2021-2026)
  8. 7.4.2 Global Short-acting Nicotine Product Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Short-acting Nicotine Product Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Short-acting Nicotine Product Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Short-acting Nicotine Product Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Nicorette (Johnson & Johnson)
  2. 8.1.1 Nicorette (Johnson & Johnson) Company Information
  3. 8.1.2 Nicorette (Johnson & Johnson) Business Overview
  4. 8.1.3 Nicorette (Johnson & Johnson) Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Nicorette (Johnson & Johnson) Short-acting Nicotine Product Product Portfolio
  6. 8.1.5 Nicorette (Johnson & Johnson) Recent Developments
  7. 8.2 Nicotinell (Haleon)
  8. 8.2.1 Nicotinell (Haleon) Company Information
  9. 8.2.2 Nicotinell (Haleon) Business Overview
  10. 8.2.3 Nicotinell (Haleon) Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Nicotinell (Haleon) Short-acting Nicotine Product Product Portfolio
  12. 8.2.5 Nicotinell (Haleon) Recent Developments
  13. 8.3 Equate (Walmart)
  14. 8.3.1 Equate (Walmart) Company Information
  15. 8.3.2 Equate (Walmart) Business Overview
  16. 8.3.3 Equate (Walmart) Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Equate (Walmart) Short-acting Nicotine Product Product Portfolio
  18. 8.3.5 Equate (Walmart) Recent Developments
  19. 8.4 Thrive (Haleon)
  20. 8.4.1 Thrive (Haleon) Company Information
  21. 8.4.2 Thrive (Haleon) Business Overview
  22. 8.4.3 Thrive (Haleon) Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Thrive (Haleon) Short-acting Nicotine Product Product Portfolio
  24. 8.4.5 Thrive (Haleon) Recent Developments
  25. 8.5 NiQuitin (Perrigo)
  26. 8.5.1 NiQuitin (Perrigo) Company Information
  27. 8.5.2 NiQuitin (Perrigo) Business Overview
  28. 8.5.3 NiQuitin (Perrigo) Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 NiQuitin (Perrigo) Short-acting Nicotine Product Product Portfolio
  30. 8.5.5 NiQuitin (Perrigo) Recent Developments
  31. 8.6 Philip Morris
  32. 8.6.1 Philip Morris Company Information
  33. 8.6.2 Philip Morris Business Overview
  34. 8.6.3 Philip Morris Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Philip Morris Short-acting Nicotine Product Product Portfolio
  36. 8.6.5 Philip Morris Recent Developments
  37. 8.7 Alkalon
  38. 8.7.1 Alkalon Company Information
  39. 8.7.2 Alkalon Business Overview
  40. 8.7.3 Alkalon Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Alkalon Short-acting Nicotine Product Product Portfolio
  42. 8.7.5 Alkalon Recent Developments
  43. 8.8 LUCY GOODS
  44. 8.8.1 LUCY GOODS Company Information
  45. 8.8.2 LUCY GOODS Business Overview
  46. 8.8.3 LUCY GOODS Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 LUCY GOODS Short-acting Nicotine Product Product Portfolio
  48. 8.8.5 LUCY GOODS Recent Developments
  49. 8.9 Dr. Reddy's Laboratories
  50. 8.9.1 Dr. Reddy's Laboratories Company Information
  51. 8.9.2 Dr. Reddy's Laboratories Business Overview
  52. 8.9.3 Dr. Reddy's Laboratories Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Dr. Reddy's Laboratories Short-acting Nicotine Product Product Portfolio
  54. 8.9.5 Dr. Reddy's Laboratories Recent Developments
  55. 8.10 Nicotex (Cipla Health)
  56. 8.10.1 Nicotex (Cipla Health) Company Information
  57. 8.10.2 Nicotex (Cipla Health) Business Overview
  58. 8.10.3 Nicotex (Cipla Health) Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Nicotex (Cipla Health) Short-acting Nicotine Product Product Portfolio
  60. 8.10.5 Nicotex (Cipla Health) Recent Developments
  61. 8.11 Swedish Match
  62. 8.11.1 Swedish Match Company Information
  63. 8.11.2 Swedish Match Business Overview
  64. 8.11.3 Swedish Match Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Swedish Match Short-acting Nicotine Product Product Portfolio
  66. 8.11.5 Swedish Match Recent Developments
  67. 8.12 Altria
  68. 8.12.1 Altria Company Information
  69. 8.12.2 Altria Business Overview
  70. 8.12.3 Altria Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Altria Short-acting Nicotine Product Product Portfolio
  72. 8.12.5 Altria Recent Developments
  73. 8.13 British American Tobacco (BAT)
  74. 8.13.1 British American Tobacco (BAT) Company Information
  75. 8.13.2 British American Tobacco (BAT) Business Overview
  76. 8.13.3 British American Tobacco (BAT) Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 British American Tobacco (BAT) Short-acting Nicotine Product Product Portfolio
  78. 8.13.5 British American Tobacco (BAT) Recent Developments
  79. 8.14 Skruf Snus
  80. 8.14.1 Skruf Snus Company Information
  81. 8.14.2 Skruf Snus Business Overview
  82. 8.14.3 Skruf Snus Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Skruf Snus Short-acting Nicotine Product Product Portfolio
  84. 8.14.5 Skruf Snus Recent Developments
  85. 8.15 Japan Tobacco International (JTI)
  86. 8.15.1 Japan Tobacco International (JTI) Company Information
  87. 8.15.2 Japan Tobacco International (JTI) Business Overview
  88. 8.15.3 Japan Tobacco International (JTI) Short-acting Nicotine Product Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Japan Tobacco International (JTI) Short-acting Nicotine Product Product Portfolio
  90. 8.15.5 Japan Tobacco International (JTI) Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Short-acting Nicotine Product Value Chain Analysis
  2. 9.1.1 Short-acting Nicotine Product Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Short-acting Nicotine Product Sales Mode & Process
  6. 9.2 Short-acting Nicotine Product Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Short-acting Nicotine Product Distributors
  9. 9.2.3 Short-acting Nicotine Product Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst